Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

Vines, Leah; Sotelo, Diana; Johnson, Allison; Dennis, Evan; Manza, Peter; Volkow, Nora D; Wang, Gene-Jack

Vines, Leah; Sotelo, Diana; Johnson, Allison; Dennis, Evan; Manza, Peter; Volkow, Nora D; Wang, Gene-Jack.

Afiliação

Vines L; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Sotelo D; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Johnson A; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Dennis E; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Manza P; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Volkow ND; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.
Wang GJ; Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, United States.

Intell Med ; 2(2): 61-68, 2022 May.

Article em En | MEDLINE | ID: mdl-35783539

Palavras-chave

Dopamine; GABA; Glutamatergic; Ketamine; NMDA; Neuroimaging; Serotonin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Intell Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google